Most current methods for assessing stem cell health and differentiation are invasive, subjective, or destructive, making them unsuitable for real-time quality control in regenerative medicine and drug screening. There is a critical need for a non-invasive, automated solution that enables accurate, high-throughput monitoring without compromising sample integrity, as the lack of such tools leads to inconsistent product quality, increased costs, and delays in clinical translation.
The technology provides a non-invasive, image-based system that uses machine learning to assess the state and functionality of stem cells and their derivatives. The system is able to predict key biological properties such as differentiation status, viability, and therapeutic potential without disrupting the cells.
Compared to traditional assays, the technology offers a competitive advantage by enabling non-invasive, real-time, and automated assessment of cell health and functionality, eliminating the need for destructive or manual testing methods. Its integration of machine learning further enhances predictive accuracy, setting it apart as a scalable, cost-effective solution for quality control in cell-based application.